Interleukin-5 inhibits glucocorticoid-mediated apoptosis in human eosinophils

Thorax

Volumn 65, Issue 12, 2010, Pages 1116-1117

  Brode, Sven ^a   Farahi, Neda ^a   Cowburn, Andrew S ^a   Juss, Jatinder K ^a   Condliffe, Alison M ^a   Chilvers, Edwin R ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

FLUTICASONE FUROATE; FLUTICASONE PROPIONATE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; INTERLEUKIN 5;

APOPTOSIS; EOSINOPHIL; EOSINOPHILIA; HUMAN; INFLAMMATION; LETTER; PRIORITY JOURNAL;

EID: 78649603174     PISSN: 00406376     EISSN: 14683296     Source Type: Journal    
DOI: 10.1136/thx.2009.124909     Document Type: Letter

References (6)

1. Barnes PJ, Adcock IM. Glucocorticoid resistance in inflammatory diseases. Lancet 2009;373:1905-17.
2. Salter M, Biggadike K, Matthews JL, et al. Pharmacological properties of the enhanced-affinity glucocorticoid fluticasone furoate in vitro and in an in vivo model of respiratory inflammatory disease. Am J Physiol Lung Cell Mol Physiol 2007;293: L660-7.
3. Simon H-U, Yousefi S, Schranz C, et al. Direct demonstration of delayed eosinophil apoptosis as a mechanism causing tissue eosinophilia. J Immunol 1997;158:3902-8.
4. Farahi N, Cowburn AS, Upton PD, et al. Eotaxin-1/CC chemokine ligand 11: a novel eosinophil survival factor secreted by human pulmonary artery endothelial cells. J Immunol 2007;15:1264-73.
5. Wallen N, Kita H, Weiler D, et al. Glucocorticoids inhibit cytokine-mediated eosinophil survival. J Immunol 1991;147:3490-5.
6. Oliver MH, Harrison NK, Bishop JE, et al. A rapid and convenient assay for counting cells cultured in microwell plates: application for assessment of growth factors. J Cell Sci 1989;92:513-18.